LRRK2 and Parkinson disease: Until now, several Tg rodent models overexpressing pathogenic LRRK2 mutants have been developed to mimic certain aspects of PD, such as selective DA neuronal loss, disruption of dopamine homeostasis, locomotor deficit or/and accumulation of tau and α-synuclein [48,49,50,51,52].